BeStock  

Haleon HLN

US equityMarket cap rank #525Drug Manufacturers - Specialty & Generic
$9.07 +$0.02 (+0.22%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $9.07 0.00%
Open$9.11
Prev close$9.05
Day range$9.07 – $9.17
Volume17.96M
Market cap$39.76B
P/E (TTM)19.1
Dividend yield2.09%

Earnings

Average move on report day±3.3%last 9 reports
Closed higher3 of 933% of the time
Best reaction+6.2%
Worst reaction-5.8%

Stock move on the day after each report

+1.4%2022/Q2-3.7%2022/Q4-2.7%2023/Q2+6.2%2023/Q4+2.0%2024/Q2-4.0%2024/Q4-2.2%2025/Q2-5.8%2025/Q4-1.7%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q230 Jul 2026None±9.8%-1.65%Within range
2025/Q425 Feb 2026None–-5.78%–
2025/Q231 Jul 2025None±12.3%-2.18%Within range
2024/Q427 Feb 2025None±5.9%-4.02%Within range
2024/Q21 Aug 2024None±15.0%+1.97%Within range
2023/Q429 Feb 2024None±8.8%+6.20%Within range
2023/Q22 Aug 2023None±27.7%-2.69%Within range
2022/Q42 Mar 2023None±7.2%-3.66%Within range
2022/Q220 Sep 2022None–+1.35%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2025/FY

By business line

  • Oral health£3.46B 31.4%
  • Pain relief£2.56B 23.2%
  • Respiratory health£1.87B 17.0%
  • Vitamins, minerals and supplements£1.69B 15.3%
  • Digestive health£987.00M 8.9%
  • Therapeutic Skin Health and Other£460.00M 4.2%

By region

  • Rest of the World£6.19B 56.1%
  • United States and Puerto Rico£3.47B 31.4%
  • China£999.00M 9.1%
  • UK£374.00M 3.4%

Latest reported quarter: Q4, ended Dec 2024 · reported in GBP

Revenue£2.76B-0.3% YoY
Operating profit£350.00M+29.2% YoY
Net profit£222.00M+3,071.4% YoY
Diluted EPS£0.05

Revenue, last 8 quarters

£3.0BMar '23£2.8BJun '23£2.8BSep '23£2.8BDec '23£2.9BMar '24£2.8BJun '24£2.8BSep '24£2.8BDec '24

Net profit, last 8 quarters

£415.0MMar '23£315.0MJun '23£374.0MSep '23£7.0MDec '23£441.0MMar '24£313.0MJun '24£499.0MSep '24£222.0MDec '24

Profitability & balance sheet

Gross margin65.0%
Operating margin21.4%
Net margin14.6%
Return on equity10.0%
Return on assets5.0%
Return on invested capital7.5%
Current ratio0.69
Liabilities / assets49.5%
Cash & investments£826.00M
Total debt£8.18B
Net cash (debt)-£7.35B
Free cash flow / sales20.0%

Discussion

No comments yet — be the first to weigh in on HLN.

Sign in to join the discussion.

Scroll to Top